Neudle.com: multiple sclerosis clinical patterns

Differential
(Click to cross reference)

abdominal cramps

abdominal reflex, absent

abortion, spontaneous

abscess, intracerebral

abscess, intracranial-fungal

abscess, lung

acute disseminated encephalomyelitis

acute disseminated encephalomyelitis, multiphasic

adenylate kinase 5 autoantibodies

advances in neurology

adverse drug reaction

alternating rapid movement

alveolar hypoventilation

Alzheimer's disease

amnesia

amnesia, anterograde

amphiphysin antibodies

amygdala

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, familial

amyotrophic lateral sclerosis, prognosis

angiotensin-converting enzyme

antibodies to measles

antibodies to myelin basic protein

antihistamines

antimyelin antibodies

arteriovenous malformation

autoimmune cerebellar ataxia

autoimmune disease

autonomic dysfunction

B cell lymphocyte depletion

B cell lymphocytes

bacterial infection

bacterial infection, CNS

Barkhof MR criteria for MS

basal ganglia

basal ganglia, hemorrhage

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

bone marrow infarction

bone marrow necrosis

bone marrow suppression

bone marrow transplantation

Borrelia burgdorferi infection

brachial neuritis

brachial plexus neuropathy

brain biopsy, indication

brainstem

brainstem, atrophy

brainstem, infarction of

CAT scan, disappearing lesion on

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, pelvis

caudate nucleus

caudate nucleus, atrophy

cavernous sinus

cavernous sinus, expansion

cavernous sinus, lesion of

central nervous system, infection of

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellar peduncle

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortex

cerebral cortical atrophy

cerebral edema

cerebral edema, vasogenic

cerebral embolism

cerebral infarction

cerebral infarction, small, deep

cerebral infarction, subcortical

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, cell count

cerebrospinal fluid, cytology

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, gold sol.curve of

cerebrospinal fluid, oligoclonal bands, absent

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, oligoclonal IgM in

cerebrospinal fluid, protein of

cerebrospinal fluid, proteincytologic dissociation

cerebrospinal fluid, xanthochromia of

cerebrovascular accident

cerebrovascular accident, familial occurrence

cerebrovascular accident, mimics

cerebrovascular accident, multiple

cerebrovascular accident, nonvascular territory

cerebrovascular accident, recurrent

cerebrovascular accident, young adult

cerebrovascular disease, cardiovascular disease with

chest x-ray

chest x-ray, abnormal

Clinical Pathologic Conference(C.P.C.)

clinicoradiologic dissociation

cognition

collapsin response mediator protein 5 IgG

congestive heart failure

contactin associated protein like 2 antibodies

controversies in neurology

conversion reaction

cop 1

corpus callosum, atrophy of

corpus callosum, lesion of

cortical blindness

cost effectiveness

cranial nerve palsies

cranial neuropathy

cranial neuropathy, multiple

craniectomy, decompressive

C-reactive protein, elevated

creatine phosphokinase(CPK)elevated

cryptococcoma, cerebral

dementia, rapidly progressive

demyelinating disease

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disease modifying agents

disorientation

dizziness

drowsiness

drug induced neurologic disorders

dysarthria

dysdiadochokinesia

dyskinesia

dyskinesia, buccal lingual facial

dysmetria

echocardiogram

efficacy

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, focal delta activity

electroencephalogram, periodic complexes

ELISA

embolism, fat

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, focal

encephalitis, paraneoplastic

encephalitis, Rasmussen's

encephalitis, recurrent

encephalitis, viral

encephalomyelitis

encephalomyelitis, postinfectious

encephalopathy

epidemiology of neurology

episodic disorders

episodic neurologic deficits

erythema migrans

EVIDENCE trial

evidence-based research

evoked potentials

eye movement, disorders of

Fabry's disease

facial nerve palsy

facial nerve palsy, bilateral

facial nerve palsy, recurrent

facial pain

facial weakness

facial weakness, bilateral

fluorescein angiography

fungal infection, CNS

gammaglobulin therapy, intravenous

gastrointestinal perforation

gender

gene mutation

genetic neurologic disorders

genetic testing

glioma

glutamic acid decarboxylase, antibody

granular osmiphilic material

granulomatosis with polyangiitis

granulomatous disease

gray matter

grimacing

Guillain Barre syndrome

hallucination

hallucination, visual

hemianopia, transient

hemifacial atrophy

hemimyoclonic jerks

hemiparesis

hemiparesis, transient

hemiplegia

hemoglobin abnormality, neurologic complications of

hepatosplenomegaly

heralding manifestation

herniated disc, lumbar-laminectomy

herpes simplex encephalitis

herpes simplex encephalitis, diagnosis of

herpes virus

herpes virus infection

herpes zoster

herpes zoster, disseminated

hip pain

hippocampal atrophy

hippocampus

hippocampus, hyperintense

HLA

human herpesvirus 6

hydrocephalus, exvacuo

hypersomnia

hypertension

hypertrophic intracranial pachymeningitis

hypertrophic pachymeningitis, IgG4 related disease

hypertrophic spinal pachymeningitis

hypogonadism

hyponatremia

hypopigmentation of skin

hypothalamus, lesion of

iatrogenic neurologic disorders

idiopathic thrombocytopenic purpura

IgG4-related disease

immunization, neurologic complications with

immunohistochemistry

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

in vitro fertilisation

inattention

incidence

inclusion bodies

inclusion bodies, eosinophilic cytoplasmic

inclusion bodies, eosinophilic intranuclear

inclusion bodies, intranuclear

infection

influenza immunization

intellectual deficit

intellectual deterioration

intracerebral hemorrhage

intracerebral hemorrhage, clot evacuation

intracerebral hemorrhage, location of

intracerebral hemorrhage, treatment of

intrauterine

intravenous

iron, serum, elevated

jaw pain

JC virus

lactic acidemia

lactic dehydrogenase(LDH)

laminectomy, lumbar

laquinimod

lesions too numerous to count

leucine rich glioma inactivated 1 antibodies

leukoencephalitis

leukoencephalopathy

leukopenia

level of consciousness

level of consciousness, decreased

life expectancy

limbic encephalitis

linomide

lipid storage disorder of CNS

liver function enzymes

lobar atrophy

long bone lesion

low back pain

lumbosacral plexopathy

lumbosacral plexus

lumbosacral plexus, neuritis

lymphadenopathy, hilar

lymphopenia

malformation, vascular

malignancy screen

malignancy, occult

Marburg's disease

McDonald criteria for MS

mediastinum, lymph-node biopsy

mediastinum, mass of

medication withdrawal

medulla oblongata, lesion of

MELAS syndrome

memory, defect of recent

memory, impairment of

meningeal biopsy

meningeal enhancement

meningismus

meningitis

meningitis, aseptic

meningitis, carcinomatous

meningitis, granulomatous

meningitis, syphilitic

meningoencephalitis

mental status, abnormal

meralgia paresthetica

mesial temporal lobe

methotrexate

microangiopathy, brain

microangiopathy, retina

midbrain, lesion of

middle cerebellar peduncle, lesion

mitochondrial disease

mitoxantrone

monoclonal antibodies

monoclonal gammopathy

mononeuropathy

mononeuropathy multiplex

MRI, contrast enhanced

MRI, contrast enhanced, delayed

MRI, contrast enhanced, high dose

MRI, demyelinating disease

MRI, diffusion tensor

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, FLAIR

MRI, high signal foci on

MRI, hypointense signal foci on

MRI, lesion burden

MRI, magnetization transfer sequence

MRI, spinal cord, increased intramedullary cord signal

MRI, spine

MRI, starfield pattern

MRI, volumetry

MRS

multiple sclerosis

multiple sclerosis, acute

multiple sclerosis, aggressive

multiple sclerosis, asymptomatic

multiple sclerosis, benign form of

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, conversion to clinically definite

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, etiology of

multiple sclerosis, familial

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, pathogenesis

multiple sclerosis, plaque

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

multiple sclerosis, without CSF bands

multiple sclerosis, worsening

muscle pain

myasthenia gravis

myasthenia gravis, paraneoplastic

myasthenic syndrome

myelin basic protein

myelitis

myelitis, longitudinal

myelitis, transverse

myeloma, osteosclerotic

myelomalacia

myelopathy

myelopathy, chronic progressive

myocardial infarction

natalizumab, discontinuation

nausea and vomiting

negative

neoplasm, primary intracerebral

neoplasm, primary of CNS

nerve conduction studies

neuroendocrinology

neurofibrillary degeneration

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic examination

neurologic practice

neurologic signs

neurologic symptoms

neuromuscular junction

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuronal cell surface antigen

neuronopathy, sensory

neuropathology

neuropathy

neuropathy, painful

neuropathy, paraneoplastic

neuropathy, peripheral, treatment

neuropathy, sensory

neuroprotective agents

neurosyphilis

neurotoxic

neutralizing antibodies

nonsteroidal anti-inflammatory drug

normal

Notch3 gene

nystagmus

nystagmus, primary position of gaze

nystagmus, vertical

occipital lobe, infarction

ocrelizumab

ocular dipping

ofatumumab

onconeural antibodies

ophthalmoplegia

opportunistic infection

opportunistic infection, CNS

opsoclonus

opsoclonus-myoclonus syndrome

optic atrophy

optic chiasm

optic chiasm, lesion of

optic neuritis

optic neuritis, bilateral

optic neuritis, recurrent

optic neuropathy

optic neuropathy, bilateral

orchitis

organomegaly

pachymeningitis, cranial

paraneoplastic cerebellar degeneration

PAS positive material in the brain

patient information and support

periaqueductal lesion

periarteritis nodosa

pericarditis

peripheral nerve, lesion of

PLEDs, bilateral independent

PLEDs, etiology of

pleocytosis of cerebrospinal fluid

pleurisy

POEMS syndrome

polymerase chain reaction

polyneuropathy

polyneuropathy, chronic inflammatory demyelinating

posterior cerebral artery territory infarction

postpartum

potassium channel antibodies

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

prognosis

progressive hemifacial atrophy

progressive multifocal leucoencephalopathy

progressive neurologic disorder

prosopagnosia

psychiatric problems in neurologic disorders

psychological testing

psychotic behavior

pulmonary edema

pulmonary infiltrates

pulmonary nodules

pupil

pupil, abnormality in neurologic disorders

pursuit eye movements, abnormal

rapidly progressing neurologic illness

rash

reading disorder, acquired

ReBUILD study

recurrent

Red flags

rehabilitation for neurologic disorders

release phenomena

remote effect of cancer on the nervous system

remyelination

renal failure

respiratory failure

reticular activating system

retinal branch artery occlusion

retinopathy

reversible neurologic disorder

review article

rheumatoid arthritis factor(R.A.factor)

risk factors

risk stratification

risk-benefit assessment

rituximab

Romberg's sign

rubeola virus

saccadic eye movements, abnormal

safety

salivation, excessive

scleroderma, neurologic involvement with

sclerosis, bone

scotoma

screening

sedimentation rate, elevated

seizure

seizure, focal

seizure, intractable

seizure, psychomotor-temporal lobe

sensorineural hearing loss

serologic testing

serologic testing of cerebrospinal fluid

seronegative

serum alanine aminotransferase

serum glutamic oxaloacetic transaminase

Sjogren's syndrome, neurologic manifestations of

skin, lesions in neurologic disorders

small vessel disease

somnolence

spinal cord

spinal cord, compression of

spinal cord, enlargement

spinal cord, lesion of

spinal cord, vascular malformation of

spinal pachymeningitis

spinal stenosis

spinal stenosis, cervical canal

spirochete infection

splenomegaly

spontaneous remission

standing difficulty

statin therapy

stem cell transplantation

steroid

steroid therapy, CNS treatment and complications with

stress, emotional

strokelike episodes

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subacute sclerosing panencephalitis, adult onset

Susac's syndrome

sweating

symmetric brain lesions

syphilis, diagnosis and treatment

syphilis, neurologic complications with

temporal artery, biopsy

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

third ventricle, enlargement of

transient neurologic deficit

trauma

treatment of neurologic disorder

tremor

tremor, intention

trigeminal neuropathy

tumor necrosis factor

tumor necrosis factor inhibitor

ulcerative colitis

unconsciousness

upward deviation of eyes

uremia

urinary tract infection

vaccination, neurologic complications with

vaccine

vascular endothelial growth factor

vasculitides

vasculopathy

ventricular enlargement

vertigo

viral infection

viral infection, CNS

viral infection, reactivation

vision, blurred

visual acuity

visual evoked response

visual loss

visual loss, sudden

visual loss, transient

visuospatial disturbance

walking, difficulty with

war

water channel antibodies

weakness

weakness, generalized

weight loss

Western immunoblot test

wheelchair

white matter disease

white matter, dirty-appearing

Showing articles 100 to 150 of 9152 << Previous Next >>

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Asymmetric Cerebellar Ataxia and Limbic Encephalitis as a Presenting Feature of Primary Sjogrens Syndrome
J Neurol 254:1609-1611, Collison,K. and Rees,J., 2007

Diagnosis and Treatment of Multiple Sclerosis
BMJ 332:525-527, Murray,T.J., 2006

Increase in Multiple Sclerosis Relapse Rate Following in vitro Fertilization
Neurol 66:1280-1281, Laplaud,D.-A.,et al, 2006

Significance of T2 Lesions in Multiple Sclerosis: A 13-Year Longitudinal Study
Ann Neurol 60:236-242, Rudick,R.A.,et al, 2006

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
NEJM 355:1124-1140, Kappos,L.,et al, 2006

Clinically Isolated Syndromes, A New Oligoclonal Band Test Accurately Predicts Conversion to MS
Neurol 66:576-578, Masjuan,J.,et al, 2006

Metabolic Disease and Stroke: MELAS
emedicine.com, Mandava,P.,et al, 2006

Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006

Effect of Mitoxantrone on MRI in Progressive MS, Results of the MIMS Trial
Neurol 65:690-695, Krapf,H.,et al, 2005

Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis: Randomised Placebo-Controlled Trial
Lancet 364:1149-1156, Hommes,O.R.,et al, 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1779-1787,1768, Kappos,L.,et al, 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1788-1795,1768, The North American Study Group on Interferon beta-, 2004

Clinical Characteristics of African Americans vs Caucasian Americans with Multiple Sclerosis
Neurol 63:2039-2045, Bree,B.A.C.,et al, 2004

Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004

Neurologic Manifestations in Primary Sjogren Syndrome: A Study of 82 Patients
Medicine 83:280-291, Delalande,S.,et al, 2004

Susac Syndrome:Report of Four Cases and Review of the Literature
AJNR 25:382-388,351, Do,T.H.,et al, 2004

Oral Simvastin Treatment in Relapsing-Remitting Multiple Sclerosis
Lancet 363:1607-1608,1570, Vollmer,T.,et al, 2004

Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-Up Study
Ann Neurol 56:303-306, Pittock,S.J.,et al, 2004

Neurologic Impairment 10 Years After Optic Neuritis
Arch Neurol 61:1386-1389, Optic Neuritis Study Group, 2004

Relapsing-Remitting Multiple Sclerosis and Human Herpesvirus 6 Active Infection
Arch Neurol 61:1523-1527, Alvarez-Lafuente,R.,et al, 2004

The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003

Self Reported Stressful Life Events and Exacerbations in Multiple Sclerosis:Prospective Study
BMJ 327:646-649, Beljevac,D.,et al, 2003

Clinical Importance of Neutralising Antibodies Against Interferon Beta in Patients with Relapsing-Remitting Multiple Sclerosis
Lancet 362:1184-1191, Sorensen,P.S.,et al, 2003

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003

Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003

Rasmussen's Encephalitis
Neurol 60:422-425, Granata,T.,et al, 2003

Randomized, Comparative Study of Interferon B-1a Treatment Regimens in MS
Neurol 59:1496-1506,1482, Panitch,H.,et al, 2002

Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002

Copaxone's Effect on MRI-Monitored Disease in Relapsing MS is Reproducible and Sustained
Neurol 59:1284-1286, Wolinsky,J.S.,et al, 2002

Immunization and MS
Neurol 59:1837-1843, Rutschmann,O.T.,et al, 2002

Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002

Assessment of Normal-Appearing White and Gray Matter in Patients with Primary Progressive Multiple Sclerosis
Arch Neurol 59:1406-1412, Rovaris,M.,et al, 2002

Early Onset Multiple Sclerosis
Neurol 59:1006-1010, Boiko,A.,et al, 2002

A Randomized, Double-Blind, Dose-Comparison Study of Weekly Interferon B-1a in Relapsing MS
Neurol 59:1507-1517,1482, Clanet,M.,et al, 2002

Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002

Isolated Demyelinating Syndromes: Comparison of CSF Oligoclonal Bands and Different MR Imaging Criteria to Predict Conversion to CDMS
Mult Scler 7:359-363, Tintore,M.,et al, 2001

The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001

Multiple Sclerosis and Magnetic Resonance Imaging
Arch Neurol 58:35-36, Racke,M.K.,et al, 2001

European/Canadian Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Effects of Glatiramer Acetate on Magnetic Resonance Imaging-Measured Disease Activity and Burden in Patients wi
Ann Neurol 49:290-297, Comi,G.,et al, 2001

Clinical and Neuroradiologic Features of Acute Disseminated Encephalomyelitis in Children
Neurol 56:1308-1312,1257, Hynson,J.L.,et al, 2001

Acute Disseminated Encephalomyelitis
Neurol 56:1313-1318,1257, Schwarz,S.,et al, 2001

Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1496-1504, Secondary Progressive Efficacy Clinical Trial of R, 2001

Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1505-1513, Li,D.K.B.,et al, 2001

Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
Ann Neurol 50:121-127, McDonald,W.I.,et al, 2001

Showing articles 100 to 150 of 9152 << Previous Next >>